info@ihfda.org

2022 Annual Conference

A hybrid conference offered in-person and virtual
September 26th - 28th, 2022
Nashville, Tn

IHFDA 6th Annual Conference

***Attend the conference and receive an IHFDA membership free for one year. A $150 dollar value***

We are pleased to announce details about the 2022 Annual Conference.  This year's conference will be held in Nashville, TN at the Franklin Marriott Cool Springs Hotel, and virtual through the Whova App (same platform as the 2021 IHFDA conference). 

This years conference promises to be the most diverse and in depth learning experience IHFDA has ever offered! Several panel discussions, case studies, and our poster offerings are just a few of this year’s exciting headliners.

In addition, IHFDA has constructed a first of its kind fundamental healthcare facility diversion certificate that is being offered in conjunction with the annual conference culminating in a live question and answer session in the morning of Day 1 in Nashville. This certificate can be taken in-person or virtually.

Conference Attendee $400
Conference RegistrationBecome an Exhibitor

Hotel 

Franklin Marriott Cool Springs
700 Cool Springs Blvd
Franklin, TN 37067
Last Day to Book: Friday, September 9, 2022
Hotel Reservations

Fundamental Drug Diversion Certificate

About Fundamental Drug Diversion Certificate
The IHFDA Executive Board could not be more excited with the advent of the brand new fundamental course on drug diversion inside healthcare facilities. This ground breaking 8 hour compilation of some of the most experienced and trusted experts in this field should prove extremely helpful whether you are just starting to seriously look at drug diversion inside your institution or you have been doing it for several years. We have provided a well rounded course that will address the main concerns of everyone who is tasked with these crucial investigations, with the ability to ask questions of the actual presenters. The presenters are either currently working on drug diversion inside a healthcare facility, or have spent many years in the field.

The first offering of this course will provide continuing education credits and will be presented virtual with live Q/A on the first day of the conference for both virutal and in-person attendees. Registrants will receive the entire 8 hour session approximately two weeks prior to our annual conference which is scheduled for September 26-28, 2022. This allows registrants two weeks to view the program and prepare for any questions they want to ask the presenters. The presenters will be in Nashville the morning of Monday, September 26th, and will take your questions virtually. If registrants are also attending the annual conference in Nashville, they can attend in person to ask their questions.

Registrants can take the virtual course for $200 unless they are also attending the annual conference, which would then provide a $50 discount, making the fee $150. Either way, continuing education credits would apply and a certificate of completion will accompany this course, the first of its kind!

This is something many of you in the field have been asking for years to be available for your new people into this area of investigation and those who desire a refresher course while also seeing the most recent methods and means of today’s investigators. Thanks for your input and support as we embark on this very important educational forum.
Fundamental Drug Diversion Certificate Agenda
"Drug Diversion: Personal Impacts, Patient Harm and Unexpected Outcomes” (1 hour)

“Overview of Institutional Drug Diversion” (1 hour)

“Drug Diversion Interviews in Healthcare: Gateway to the Truth” (1 hour)

“The Public Health Perspective: Injectable Drug Diversion and Bloodborne Pathogens Transmission” (1 hour)

“Developing a Comprehensive Drug Diversion Monitoring Program” (3 hours)

“The Intersection of Peer Support and Substance Use Disorder in Nurses” (1 hour)

Full Details about the Fundamental Drug Diversion Certificate

Conference Agenda

Download Agenda
**Agenda is subject to change**
Day 1
Day 2
Day 3
Poster Presentations
9/26/2022 - Monday 
10:00 A.M. - 11:30 A.M.
Fundamental Drug Diversion Certificate Panel Discussion & Final Remarks
**Attendance is restricted to certificate participants only**
12:00 P.M. – 12:30 P.M.
Welcome and Opening Remarks – Start of Annual Conference
12:30 P.M. – 1:30 P.M.
“The Stairs on Billy Buck Hill”
Dr. Steven Orebaugh, University of Pittsburgh
1:30 P.M. – 2:30 P.M.
“The Discovery of a Complex “Look-a-like” Medication Swap Diversion Scheme and the Associated Outcomes"
Adam Beeler, The University of Kansas Health System
2:30 P.M. – 2:45 P.M.
BREAK WITH EXHIBITORS
2:45 P.M. – 3:45 P.M.
"Just or Unjust: How Organizational Culture Impacts the Healthcare Worker with Substance Use Disorder During a Drug Diversion Investigation"
Amanda Hays & Becky Doerhoff, Becton, Dickinson and Company
3:45 P.M. – 5:15 P.M.
Topic Focused Session:
Road Map for Diversion Investigation Employee Interviews
Cory Luper & Michael Carico, Atrium Health Wake Forest Baptist

Discussing Processes and Demonstrating Skills Required for Interviewing
Terri Vidals & Bethanie Gamble, Rxpert Solutions
5:15 P.M. – 6:00 P.M.
Closing Remarks & Time with Exhibitors
9/27/2022 - Tuesday
9:00 A.M. – 9:30 A.M.
IHFDA Membership Meeting and Business Updates
9:30 A.M. – 10:30 A.M.
“Wasting Time: Perioperative and Post-Discharge Medication Management, Wasting, and Patient Returns, Altering the Trajectory of the Opioid Crisis”
Jeffrey Wahl & Dr. Evan Kharasch, MIDAS Healthcare Solutions, Inc.
10:30 A.M. – 11:30 A.M.
"Ready for my Close Up! Implementing, Maintaining, and Expanding Drug Diversion Prevention Cameras"
Jesus Rodriguez, Jeremy Quinn, Shawn Young, & John Bailey
St. Jude Children’s Research Hospital
11:30 A.M. – 12:15 P.M.
Lunch & Time with Exhibitors
12:15 P.M. – 1:15 P.M.
"Drug Diversion Prevention Shouldn’t End at Termination: Why We Must Report All Diversion"
Rajesh Speer, UAB School of Medicine
Lauren Lollini, IHFDA
1:15 P.M. – 2:45 P.M.
Topic Focused Panel: Drug Testing
Bill Bundy, Millennium Health (Toxicologist – SME)
Michael Kalisher, UC Health (Random Drug Testing)
Alecia Pittman, Cooper University Health Care (For Cause Testing)
2:45 P.M. – 3:30 P.M.
Poster Presenter Session & Break
3:30 P.M. – 4:30 P.M.
"Enhancing a Drug Diversion Prevention Program: The Impact of Guidelines and Lean Tools"
Sharon Coffie & Elizabeth Daniel, UT Southwestern Medical Center
4:30 P.M. – 6:00 P.M.
Topic Focused Session:
 A Second Chance for Success, De-Stigmatization of Frontline Diversion Detection and Employee Assistance at a Large Academic Health-System
Alexandre Raymond & Cindy Mousa, Ochsner Health

Alternative to Discipline, An Opportunity for Change
Stephen Webster, University of Rochester Medical Center
9/28/2022 - Wednesday
9:00 A.M. – 9:15 A.M.
Opening Remarks
9:15 A.M. – 10:15 A.M.
"Experience from Cross-Program, Multidisciplinary Team Investigations of Injectable Drug Diversion in Tennessee to Raise Awareness of Bloodborne Pathogen Transmission, 2020-2021"
Christopher Evans & Shirley Pickering, Tennessee Department of Health
10:15 A.M. – 11:45 A.M.
Topic Focused Panel: Medication Waste Testing
Testing for Suspicion & Medications Removed from Facility
Sushmita Shankar, Southern Illinois Healthcare

Perioperative Testing
Danielle Neal & Leah Mitchell, Atrium Health Wake Forest Baptist

Anesthesiology Waste Testing
Karen Kist, Nemours Children’s Health
11:45 A.M. – 12:30 P.M.
Lunch – Poster Sessions & Exhibitors
12:30 P.M. – 1:30 P.M.
"The Six Rights of Wasting: Decreasing the Opportunity for Diversion"
Fara Bowler, UC Health
1:30 P.M. – 2:30 P.M.
"The Value of Routine Cycle Counts"
Maureen Burger & Colleen Connelly, Visante Consulting LLC
2:30 P.M. – 2:45 P.M.
BREAK WITH EXHIBITORS
2:45 P.M. – 3:45 P.M.
"NIH Funded Research Summarizing the Value of Drug Diversion Software in Health Systems"
Tom Knight, Invistics
3:45 P.M. – 4:45 P.M.
What to Expect: DEA On-Site Inspection
Dwayne Jeffcoat, DEA
4:45 P.M. – 5:00 P.M.
CLOSING REMARKS

On the Road Again: The Diversion Challenges and Solutions with Float and Travel Staff
Susie Aboulhosn & Melissa Inscoe, Vanderbilt University Medical Center
Development of an Effective Compliance and Surveillance Program
Caroline Carter & Sheetal Patel-House, UNC Health
The Limitations of Report-Based Systems: Results of One Facility’s Drug Diversion Implementation
Kenneth Mishark, Mayo Clinic Arizona
It Takes a Village: How Networking and Collaboration Strengthen a Diversion Prevention Program
Jodi Emmett, Sarasota Memorial Healthcare System
Denise Hickey, Tampa General Hospital
Holly Borkowski, Lee Health, Fort Meyers
Implementing AI Diversion Prevention Program: Unexpected Benefits
Linda Gordon, UCHealth
Uncharted Territory: Drug Diversion Prevention in the Care Continuum
Amanda Hays, Becton, Dickinson and Company
We Want to Do Our Part! Incorporating a Permanent Medication Disposal Drop Box Right into Your Opioid Epidemic Strategy
Angela Livingood, Novant Health
Selection and Implementation of a Drug Diversion Software Application to Enhance Current Drug Diversion Surveillance in a Not-for-profit Health Care System
JoAnne Myhre, Allina Health
Healthcare System Centralized Drug Diversion Services
Danielle Neal & Leah Mitchell, Atrium Health Wake Forest Baptist

2022 Conference Exhibitors (A-Z)

ARL Bio Pharma - IHFDA Corporate MemberBD - IHFDA Corporate MemberBaptist Memorial Health CareHCA HealthcareHelioMetrics - IHFDA Corporate MemberMethodist Le Bonheur HealthcareProtenus
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram